Skip to content
Disclosery

13F-HR filed by Pennant Investors, LP

Pennant Investors, LP filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 46 holding rows worth $382,572,880.

Accession
0000919574-24-004628
Filer
CIK 1759176
Filed
2024-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2024

A holdings report, 46 entries on the cover page, a total value of $382,572,880 stated on the cover page (in dollars after the unit check, H1), rows summing to $382,572,880 with VALUE read as dollars as filed, 13F file number 028-18953. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Micron Technology,Inc.595112103COM431,000$56,689,430dollars as filed
Amazon.com, Inc023135106COM240,000$46,380,000dollars as filed
TRANSDIGM GROUP INC COM893641100Stock32,371$41,357,513dollars as filed
ECHOSTAR CORP278768106CL A2,153,209$38,348,652dollars as filed
Microsoft Corp594918104COM80,000$35,756,000dollars as filed
Alphabet Inc. Reg. Shares A02079K305COM183,000$33,333,450dollars as filed
ANTERO RESOURCES CORP COM03674X106Stock836,000$27,278,680dollars as filed
PERIMETER SOLUTIONS SAL7579L106COMMON STOCK-FO2,300,000$18,009,000dollars as filed
ANTERO RESOURCES CORP COM03674X106Stock500,000$16,315,000dollars as filedcall
THE ODP CORP88337F105COM400,000$15,708,000dollars as filed
VALMONT INDS INC COM920253101Stock40,000$10,978,000dollars as filed
GE Vernova Inc.36828A101COM60,000$10,290,600dollars as filed
VERTIV HOLDINGS CO COM CL A92537N108Stock115,000$9,955,550dollars as filed
IRENLTDFQ4982L109STOK470,000$5,306,300dollars as filed
CORE SCIENTIFIC INC NEW21874A106COM500,000$4,650,000dollars as filed
ARCUTIS BIOTHERAPEUTICS INC03969K108COM170,900$1,589,370dollars as filed
NURIX THERAPEUTICS INC67080M103COMMON STOCK56,800$1,185,416dollars as filed
NOVAVAX INC670002401COM NEW60,300$763,398dollars as filed
ALTIMMUNE INC02155H200COM NEW109,800$730,170dollars as filed
FIBROGEN INC31572Q808COM768,400$685,643dollars as filed
AGIOS PHARMACEUTICALS INC00847X104COM15,100$651,112dollars as filed
FATE THERAPEUTICS INC31189P102COM146,100$479,208dollars as filed
TRAVERE THERAPEUTICS INC89422G107COM55,800$458,676dollars as filed
ENANTA PHARMACEUTICALS INC29251M106COM35,100$455,247dollars as filed
IGM BIOSCIENCES INC449585108COM64,900$445,863dollars as filed
ERASCA INC COM29479A108Stock166,200$392,232dollars as filed
ARCUS BIOSCIENCES INC03969F109COM23,700$360,951dollars as filed
89BIO INC282559103COM44,500$356,445dollars as filed
ZYMEWORKS INC98985Y108COM38,700$329,337dollars as filed
ARCTURUS THERAPEUTICS HLDGS03969T109COM13,100$318,985dollars as filed
ALLOGENE THERAPEUTICS INC019770106COM128,400$299,172dollars as filed
COHERUS ONCOLOGY INC19249H103COM168,100$290,813dollars as filed
RELAY THERAPEUTICS INC COM75943R102Stock42,400$276,448dollars as filed
REPLIMUNE GROUP INC76029N106COMMON STOCK30,500$274,500dollars as filed
UNIQURE NVN90064101SHS48,500$217,280dollars as filed
SERES THERAPEUTICS INC81750R102COM292,300$211,567dollars as filed
COMPASS THERAPEUTICS INC20454B104COM199,000$199,000dollars as filed
SAGE THERAPEUTICS INC78667J108COM17,500$190,050dollars as filed
GETAROUND INC37427G101COM1,348,153$188,741dollars as filed
MACROGENICS INC556099109COM43,800$186,150dollars as filed
ALLAKOS INC01671P100COM186,100$186,100dollars as filed
ALLOVIR INC019818103COM215,700$156,016dollars as filed
ZENTALIS PHARMACEUTICALS INC98943L107COMMON STOCK32,400$132,516dollars as filed
BIOXCEL THERAPEUTICS INC09075P105COM83,900$107,392dollars as filed
BLUEBIRD BIO INC09609G100COM87,400$86,019dollars as filed
GRAB HOLDINGS LIMITEDG4124C117*W EXP 99/99/99980,000$12,888dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-24-004628this filing2024-08-14acceptance time not in the bulk data set